LIGAND PHARM CMN STK LGND (NASDAQ)

$ 3.06
19:09
Change: -0.13 (-4.08%)
Volume: 281,900

Avg. Volume: 533335
P/E Ratio: 0
EPS (Annual): -0.04
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 94,920
Institutional Shareholders: 99.96%
Last: 3.06
Change: -0.13 (-4.08%)
Prev. Close: 3.19
Open: 3.17
Day's Range: 3.05 - 3.34
52wk Range: 2.16 - 6.58
Market Value: 320,820
Beta: 2.15
12-month EPS Change: -100.96%
Total Return Last 12 Months: -50.31%
Total Return Last 3 Years: -34.89%
Total Return Last 5 Years: -71.52%
5-Year Revenue Growth Rate: -86.66%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: -710.64%


Headlines on LGND
Alert me Subscribe

FDA schedules meeting on drug from Pfizer, Ligand

(WASHINGTON)Federal medical advisers will meet next month to review an experimental drug to treat osteoporosis from Pfizer Inc. and Ligand Pharmaceuticals Inc. The Food and Drug Administration...READ MORE
Aug 06, 2008 12:11PM
Keywords: PFE, LGND

Ahead of the Bell: Amgen blood-clotting drug

(WASHINGTON)Biotech drugmaker Amgen Inc. is expected to receive a decision this week from federal regulators on its experimental drug to treat a blood-clotting disorder.READ MORE
Jul 22, 2008 6:19AM
Keywords: AMGN, GSK, LGND

Ligand says FDA extends blood-clot drug review

(NEW YORK)Drug developer Ligand Pharmaceuticals Inc. said after the bell Friday the Food and Drug Administration will take an additional three months to review its experimental blood-clottin...READ MORE
Jun 20, 2008 4:31PM
Keywords: LGND, GSK

Alphatec Spine names Peter Wulff as CFO

(CARLSBAD, Calif.)Medical device maker Alphatec Spine, a unit of Alphatec Holdings Inc., said Monday it named Peter C. Wulff as chief financial officer and treasurer. Wulff most recently served as C...READ MORE
Jun 16, 2008 9:00AM
Keywords: ATEC, ARTE, NAII, LGND

FDA panel favors Glaxo, Ligand blood drug

(WASHINGTON)Advisers to the Food and Drug Administration said Friday a blood-clotting drug from GlaxoSmithKline PLC and Ligand Pharmaceuticals Inc. is effective for short-term use, despite res...READ MORE
May 30, 2008 5:06PM
Keywords: GSK, LGND, AMGN

FDA panel favors Glaxo, Ligand blood drug

(WASHINGTON)Advisers to the Food and Drug Administration said Friday a blood-clotting drug from GlaxoSmithKline PLC and Ligand Pharmaceuticals Inc. is effective for short-term use, despite res...READ MORE
May 30, 2008 4:56PM
Keywords: GSK, LGND, AMGN

Glaxo, Ligand drug gets negative FDA assessment

(NEW YORK)The Food and Drug Administration said Wednesday GlaxoSmithKline PLC's blood-clotting disorder drug Promacta is no more effective than placebo, sending shares of longtime partne...READ MORE
May 28, 2008 6:40PM
Keywords: LGND, AMGN, GSK
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +41.30 63.81
GILEAD SCIENCES +39.10 54.15
BIOGEN IDEC INC -7.60 53.16
GENENTECH INC +43.70 97.43
AMYLIN PHARMA I -42.70 26.68